Wilbanks Smith & Thomas Asset Management LLC Corcept Therapeutics Inc Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$11.29 - $17.19 $1,129 - $1,719	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $1,227 - $1,565	100 New	100 $1,000

Others Institutions Holding CORT

# of Institutions

316

Shares Held

93.8M

Call Options Held

2.02M

Put Options Held

3.24M

Black Rock Inc. New York, NY

16.8M
Shares

$506 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

9.57M
Shares

$288 Million
0.0% of portfolio
Ingalls & Snyder LLC New York, NY

8.3M
Shares

$250 Million
9.24% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

7.12M
Shares

$214 Million
0.28% of portfolio
Parallel Advisors, LLC

3.82M
Shares

$115 Million
2.62% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.22B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account